KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Regeneron Pharmaceuticals (REGN) Shares Repurchased (2018 - 2025)

Historic Shares Repurchased for Regeneron Pharmaceuticals (REGN) over the last 8 years, with Q4 2025 value amounting to $671.7 million.

  • Regeneron Pharmaceuticals' Shares Repurchased fell 3096.61% to $671.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 billion, marking a year-over-year increase of 3208.62%. This contributed to the annual value of $3.4 billion for FY2025, which is 3208.62% up from last year.
  • As of Q4 2025, Regeneron Pharmaceuticals' Shares Repurchased stood at $671.7 million, which was down 3096.61% from $664.0 million recorded in Q3 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Shares Repurchased ranged from a high of $1.1 billion in Q2 2025 and a low of $166.4 million during Q3 2021
  • For the 5-year period, Regeneron Pharmaceuticals' Shares Repurchased averaged around $600.3 million, with its median value being $633.9 million (2024).
  • Its Shares Repurchased has fluctuated over the past 5 years, first crashed by 9395.99% in 2021, then surged by 46165.87% in 2022.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Shares Repurchased stood at $866.9 million in 2021, then tumbled by 50.27% to $431.1 million in 2022, then tumbled by 32.96% to $289.0 million in 2023, then soared by 236.68% to $973.0 million in 2024, then tumbled by 30.97% to $671.7 million in 2025.
  • Its Shares Repurchased was $671.7 million in Q4 2025, compared to $664.0 million in Q3 2025 and $1.1 billion in Q2 2025.